Mark A. Goldsmith - 30 Jun 2025 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Issuer symbol
RVMD
Transactions as of
30 Jun 2025
Net transactions value
+$19,980
Form type
4
Filing time
02 Jul 2025, 16:11:45 UTC
Previous filing
18 Jun 2025
Next filing
18 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GOLDSMITH MARK A President and Chief Executive Officer, Director C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY /s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith 02 Jul 2025 0001246842

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $19,980 +37,000 +8.6% $0.5400 465,720 30 Jun 2025 Direct F1
holding RVMD Common Stock 20,424 30 Jun 2025 Trust F2
holding RVMD Common Stock 20,424 30 Jun 2025 Trust F3
holding RVMD Common Stock 465,604 30 Jun 2025 Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -37,000 -18% $0.000000 168,503 30 Jun 2025 Common Stock 37,000 $0.5400 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 218,188 restricted stock units.
F2 Held by Jonathan Goldsmith Revocable Trust.
F3 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F4 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Remarks:

President and Chief Executive Officer